{"id":"W4321611533","doi":"10.1007/s40744-023-00533-5","title":"Response to Treatment with Intravenous Golimumab or Infliximab in Rheumatoid Arthritis Patients: PROMIS Results from the Real-World Observational Phase 4 AWARE Study","year":2023,"lang":"en","type":"article","venue":"Rheumatology and Therapy","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Saskatchewan","funders":"Janssen Research and Development; Janssen Scientific Affairs","keywords":"Golimumab; Infliximab; Observational study; Rheumatoid arthritis; Medicine; Phase (matter); Physical therapy; Internal medicine; Adalimumab; Tumor necrosis factor alpha","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003379361,0.0005677157,0.0008950855,0.0004145646,0.0002860465,0.0009417102,0.0005317131,0.0006572401,0.0006346155],"category_scores_gemma":[0.003900595,0.0004593703,0.00117876,0.0007042936,0.0003686074,0.0004638512,0.0005427889,0.0006527832,0.0002194818],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003346131,"about_ca_system_score_gemma":0.000510017,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008423157,"about_ca_topic_score_gemma":0.001233965,"domain_scores_codex":[0.9975786,0.001511613,0.000264299,0.0002346836,0.0003103741,0.0001005785],"domain_scores_gemma":[0.9950412,0.001008598,0.002603679,0.0006417765,0.0002746631,0.0004300841],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04025564,0.003403451,0.9387923,0.0003903802,0.003421599,0.0001413037,0.0003887165,0.0005427634,0.002024935,0.00005210128,0.0005835253,0.01000329],"study_design_scores_gemma":[0.009786587,0.009786605,0.9766757,0.00005317958,0.001058738,0.000387215,0.0001650088,0.0004200058,0.0005051127,0.00004295956,0.001083629,0.00003532517],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9979883,0.0003326034,0.00009943324,0.00002870582,0.00000417184,0.0001764069,0.001141981,0.000004741049,0.0002235165],"genre_scores_gemma":[0.9944032,0.0002674,0.0005072415,0.0000944272,0.0000259075,0.0003974455,0.00417831,0.000003154368,0.0001227555],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003379361,"threshold_uncertainty_score":0.01787198,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04390652984428994,"score_gpt":0.3296015249212063,"score_spread":0.2856949950769163,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}